Although the expression of MT1G in breast, thyroid cancer, and hepatocellular carcinoma was downregulated compared to that in non-cancerous tissue, it has been reported that the expression of MT1G in NSCLC is higher than that in non-malignant lung tissues [21, 77–79]. This evidence concerns the gene MT1G and thyroid gland carcinoma.